Haemonetics price target raised to $93 from $90 at Barrington
Barrington raised the firm’s price target on Haemonetics (HAE) to $93 from $90 and keeps an Outperform rating on the…
Barrington raised the firm’s price target on Haemonetics (HAE) to $93 from $90 and keeps an Outperform rating on the…
Orthofix Medical Inc. (NASDAQ:OFIX) is one of the best medical device stocks to buy according to analysts. Barrington analyst Michael Petusky…